Chronic Daily Headache in a Patient With Nasopharyngeal Carcinoma  by Chen, Jiann-Jy & Chen, Dem-Lion
J Chin Med Assoc • December 2010 • Vol 73 • No 12660
© 2010 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
Introduction
Chronic daily headache (CDH) comprises a group of
headache disorders where the headache occurs at a 
frequency greater than 15 days per month and lasts
more than 4 hours a day over a 3-month period. CDH
includes chronic migraine, chronic tension-type head-
ache, new daily persistent headache, hemicrania 
continua and medication overuse headache (MOH)
(Table 1).1–4 The prevalence of CDH is about 4–5%
in the general Taiwan population.5 The presence of
CDH in a patient with nasopharyngeal carcinoma
(NPC)6,7 is usually attributed to skull-base invasion,
intracranial metastasis or skull-base osteoradionecrosis.
Such a possible diagnosis may panic sufferers and/or
make them depressed. CDH in patients with NPC is a
multidisciplinary challenge, and for this reason, we
report the present case.
Case Report
The patient was a right-handed 42-year-old female
with B blood type and a height of 148 cm, a weight of
46 kg, and a body mass index of 21.0 kg/m2. She was
not addicted to tobacco, alcohol, betel nut or any
medication. She was not suffering from hypertension,
diabetes mellitus, heart disease, migraine or other sys-
temic disease. Two years previously, a mass measuring
about 4 × 4 cm had been noted in her left neck at 
level II over 2 weeks. This was proven histologically to
be an undifferentiated NPC (Figure 1A). After a series
of studies, a T3N1M0 stage III (American Joint Com-
mittee on Cancer, 6th edition) NPC was confirmed.
From that time onwards, the patient was bothered by
daily headaches.
In the next 3 months after the diagnosis of NPC,
she received combined chemoradiotherapy. Despite
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the fact that the NPC remitted, the headaches contin-
ued to occur every day. Over the following year, the
patient regularly received otorhinolaryngological local
treatments and swallowing rehabilitation for radiation
mucositis. She was taking 4 tablets of acetaminophen
500 mg and 4 tablets of ibuprofen 400 mg daily. The
intensity of the headaches decreased, but the headaches
did not stop.
A more recent nasopharyngeal examination, com-
puted tomography (Figure 1B) and Tc-99m whole
body bone scan did not show any abnormality, but the
attending physician informed her that there was the
possibility of intracranial or skull-base invasion. As a
result, she felt panic and became depressed. In April
2008, she consulted the first author (J.J. Chen) for a
second opinion.
Physical examination showed that the patient’s
blood pressure was 121/70 mmHg, heart rate was 
65 beats/min, body temperature was 36.5°C, and res-
piratory rate was 17breaths/min. Deep tendon reflexes
in all 4 limbs were symmetrically normal. Her pin-
prick sensation was intact. Her muscle strength was
graded 5/5 on the Medical Research Council scale.
The responses to bitter, salty and sweet stimulation in
terms of taste sensations were all intact. The finger-
to-nose tracing test and the heel-knee-shin test were
both normal. The patient could not recall the ante-
ceding characteristics of the headaches. As a result of
the above, she was invited to fill in a headache diary
over the following month.
The 1-month headache diary (Table 2) revealed that
the patient had a low-grade holocephalic headache that
Table 1. Classification of chronic migraine and medication overuse headache (ICHD-IIR)
Chronic migraine3 Medication overuse headache*4
*Diagnosis of medication overuse headache can be given before 2-month withdrawal period has elapsed, e.g. diagnosis should be made in patients with 
primary headache and concurrent medication overuse.
A. Headache (tension-type and/or migraine) on at least 
15 days/mo for at least 3 mo
B. Occurring in a patient who has had at least 5 attacks
fulfilling criteria for migraine without aura
C. On at least 8 d/mo for at least 3 mo, headache has
fulfilled C1 and/or C2 below, that is, has met criteria for
pain and associated symptoms of migraine without aura
C1. Has at least 2 of the below factors: unilateral location,
pulsating quality, moderate or severe pain intensity,
aggravated by or caused by routine physical activity
(e.g. walking or climbing stairs), nausea and/or
vomiting, photophobia and phonophobia
C2. Treated and relieved by triptan(s) or ergot before the
expected development of C1 above
D. No medication overuse and not attributed to another
causative disorder
A. Headache present on at least 15 d/mo
B. Regular overuse for over 3 mo of at least 1 acute/
symptomatic treatment drug, as defined under either
subform below
(1) Ergotamine, triptans, opioids, or combination analgesic
medications on 10 d/mo on a regular basis for over
3 mo
(2) Simple analgesics or any combination of ergotamine,
triptans, analgesic opioids on 15 d/mo on a regular
basis for over 3 mo without overuse of any single class
alone
C. Headache has developed or markedly worsened during
medication overuse
A B
Figure 1. (A) Two years before the current admission, computed tomography showed the presence of a nasopharyngeal carcinoma
located on the left side of the nasopharynx (arrow). (B) Combined chemoradiotherapy cured the patient of nasopharyngeal carcinoma,
and a recent computed tomography study showed her nasopharynx to be smooth and the patient well.
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was associated with phonophobia and photophobia.
The symptomatic duration averaged 9.1 ± 6.8 hours.
During menstruation, the headache influenced her life
and work because it became throbbing. In this circum-
stance, the headache usually involved the left orbito-
temporal area, lasted all day, and was associated with
nausea, vomiting and left upper limb paresthesia.
According to the International Classification of Head-
ache Disorders, 2nd edition, with further modifications
in 2006 (ICHD-IIR),2–4 the diagnosis of chronic
migraine superimposed on MOH was made.
Therefore, we persuaded the patient to undergo
an outpatient detoxification course. Two tablets of
dihydroergotamine mesylate 5 mg and 3 tablets of
prochlorperazine 5 mg were recommended to be taken
every 12 hours daily. Switching back and forth between
belief and suspicion, she ceased taking the painkillers
that she had become habituated to. Over the following
week, the headache abated and the daily symptomatic
duration decreased to half an hour. Henceforth, she
became free from painkillers. Over the next 6 months,
the headaches became more and more unimportant
and eventually were not noticed, even though she was
not receiving any prophylactic treatment.
Discussion
It is now recommended that a diagnosis of MOH
should no longer need to show improvement after
discontinuation of medication overuse but should be
given to patients if they have a primary headache plus
ongoing medication overuse.4 In this case, the patient
could not recall the anteceding characteristics of CDH,
and we therefore did not know what sort of headache
induced her CDH before medication overuse. Even-
tually, when her headache diary was examined, the
diagnosis of chronic migraine superimposed on MOH
was made according to the ICHD-IIR (Table 1).2–4
The prevalence of MOH is about 1% in the Taiwan
general population.8 In total, about 48% (895/1,861)
of all CDHs are MOHs. The medications overused
include both simple analgesics (46%) and compound
analgesics (54%). Medication overuse may contribute
to the development or the prolongation of chronic
post-traumatic headache because MOH prevails in
18.8–45.8% of those with chronic post-traumatic
headache.9,10 Even among chronic cluster headache
patients, the prevalence of MOH is approximately
4%.11 Thus, any patient with CDH might have a case
of medication overuse.
Outpatient or inpatient detoxification should be
recommended for MOH. At present, intravenous 
dihydroergotamine is not available in Taiwan. There-
fore, repetitive intravenous prochlorperazine is the
first-line treatment for refractory CDH with or 
without medication overuse. If necessary, diphen-
hydramine may also be given orally before sleeping 
as a prophylaxis for extrapyramidal symptoms.12 Our
patient’s headache diary could be interpreted as
chronic migraine, and therefore dihydroergotamine
mesylate was recommended during detoxification in
addition to oral prochlorperazine. Over the following
week, she tolerated the detoxification well, and there
were no rebound headaches, so hospitalization was
unnecessary.
It is possible that medication overuse precedes and
is a risk factor for CDH. Alternatively, people with
frequent headaches may take medication in response
to the pain.13 Medication overuse can also possibly be
an exacerbating factor. In this context, analgesic over-
use is considered neither necessary nor sufficient to
induce CDH.13 Thus, it remains controversial as to
whether analgesic overuse is a cause or a consequence
of CDH.13 Although skull-base invasion or intracranial
metastasis was thought to contribute to our patient’s
CDH during her initial examination for these head-
aches, these were ruled out by the imaging studies. In
these circumstances, the risk factors for CDH should
have been modified by appropriate strategies at the
beginning of treatment, and these should have included
a limited use of acute medications for no more than
10 days a month.13
Taking the above as a whole, we did not know
what sort of headache the patient was suffering from
before medication overuse. Her headaches were only
gradually relieved when the medication overuse was
eliminated, so we cannot entirely ascribe the MOH
remission to detoxification. With the help of the
patient’s headache diary, the diagnosis of chronic
migraine superimposed on MOH was made according
to the ICHD-IIR. This case has important implica-
tions for otorhinolaryngologists, oncologists and radio-
oncologists in terms of diagnosis and treatment. We
hope that by noting this case as an example, the quality
of life of such patients can be improved and medica-
tion overuse avoided.
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